CN101020033B - Medicine for treating renal calculus - Google Patents

Medicine for treating renal calculus Download PDF

Info

Publication number
CN101020033B
CN101020033B CN2007100657121A CN200710065712A CN101020033B CN 101020033 B CN101020033 B CN 101020033B CN 2007100657121 A CN2007100657121 A CN 2007100657121A CN 200710065712 A CN200710065712 A CN 200710065712A CN 101020033 B CN101020033 B CN 101020033B
Authority
CN
China
Prior art keywords
medicine
radix
herba
rhizoma
calculus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007100657121A
Other languages
Chinese (zh)
Other versions
CN101020033A (en
Inventor
唐建华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2007100657121A priority Critical patent/CN101020033B/en
Publication of CN101020033A publication Critical patent/CN101020033A/en
Application granted granted Critical
Publication of CN101020033B publication Critical patent/CN101020033B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The medicine for treating renal calculus is prepared with lysimachia herb, Chinese pink herb, Japanese felt fern frond, achyranthes root, chicken's gizzard membrane and other 15 kinds of Chinese medicinal materials in certain weight proportion. The medicine of the present invention has effect of improving kidney function, excellent treating effect on renal calculus and other urinary system calculus, and high treating effect on repeated urinary system infection.

Description

A kind of medicine for the treatment of renal calculus
Technical field
The present invention relates to Chinese patent drug technique field, specifically a kind of medicine for the treatment of renal calculus.
Background technology
The whole world has people more than 900,000,000 to suffer from this disease at present.Renal calculus patient has 1,000,000 people to need hospitalization every year; China and area, Asia are Iithiasic hotspots, but owing to there is nearly 50% patient generally not have manifest symptom, and disease is once outbreak, and pain is just violent especially.
At present, the comparatively popular Therapeutic Method in countries in the world mainly is operative therapy and microwave rubble therapy.Operative therapy general therapeutic expense is higher, has not only caused very big misery to patient. and safety is also lower, the wound that causes will return to one's perfect health, and wants six months at the soonest, and postoperative may bring adverse effect to the reproductive system function.Microwave rubble therapy is the Iithiasic method of comparatively popular treatment that occurs in recent years, but because the microwave lithotrite is expensive, thereby it is high to have caused this method to treat Iithiasic expense.With regard to the safety of calculus treatment, operative treatment is the most troubling.Main is the problem that these two kinds of therapies all can not solve residual stones and recurrence of hepatolithiasis, and therefore, hands xylotherapy and microwave rubble therapy are all cured the symptoms, not the disease.Famous calculi therapy expert professor Lang Beier of France points out: " patient that has repeatedly treats still and can not cure, the operative treatment calculi in vivo is not fully up to expectations ".According to the clinical feedback of China, the relapse rate of China calculus staff postoperative 3-5 accounts for more than 65%, and the operation retained calculus accounts for 10%-25%, and postoperative complication accounts for 15%; Except that above-mentioned reason, also have quite a few lithiasis patient to treat owing to reasons such as body constitution, age can't adopt operation or microwave rubble therapy, therefore, must seek help from the mode of Drug therapy.The calculi therapy medicine is developed in the strong appealing of countries in the world medical expert as early as possible.Internationally famous calculus expert professor Bu Qieer calls on urgently: " dissolving the part that calculus is modern internal medicine business with oral therapy ".
Iithiasic of a great variety, in China huge patient group is arranged, this situation is put the market space that wide expansion is provided for the calculus curative undoubtedly.Past, although China people have asked the Iithiasic secret recipe of many treatments, proved recipe, owing to fail to carry out industrialization production, so these valuable traditional medicine resources fail to obtain abundant development and utilization.All kinds of calculus all have the higher rate of accepting for medical treatment in China each department, be many with cholelithiasis and renal calculus especially.
From the Iithiasic economic benefit of oral drug therapy, the oral drug therapy method is except the misery of the few patient body of alkali, the more important thing is the financial burden that has alleviated them simultaneously, by contrast, with operation or microwave lithotripsy in treatment, not only the expense of treatment itself is higher, adds that charge for loss of working time etc. also is a considerable spending.
Kidney urinary calculus pathogenic factor has following several nothing more than: the one, and drinking-water, contained mineral is too much in the diet; The 2nd, the three-dimensional shock motion of people is few; The 3rd, damp-heat in lower-JIAO is exaggerated, and decocts knot and gathers into sandstone; The 4th, suffering from a deficiency of the kidney influences the wriggling of urine osmotic pressure and evacuator row and holds in both hands and let out power, thereby turbid urine is accumulated into sandstone. and in all urinary calculus, be basic intrinsic factor to suffer from a deficiency of the kidney, and some other extrinsic factor.Urinary calculi card main performance waist dull pain or waist abdomen traction angor, well weighs down distending pain to the lower abdomen perineum.Calculus is blocked sharp internal organs in vivo for a long time the probability that causes renal failure and cancer.And also other functions of remote-effects of renal calculus.Therefore, discharge calculi in vivo and seem very important.The medicine of all kinds of in the market treatment renal calculuss is more, but therapeutic effect is not ideal mostly.
Summary of the invention
The purpose of this invention is to provide and a kind ofly start with, increase the ureteral peristalsis function, thereby reach the medicine of fossil, urinary calculus removing treatment renal calculus from recovering, strengthen renal function.
The present invention adopts the breakthrough therapy, primarily is the kidney invigorating, promotes the osmotic pressure of urine to increase, and strengthens the wriggling of corresponding organs and drains power, promotes urine to generate, and strengthens the scouring force to calculus, and heat clearing away and removing heat from blood, blood normally have irreplaceable effect to diuresis.Eliminate damp-heat in lower-JIAO, the blood circulation promoting regulates qi analgesia to alleviate the kidney load, impels renal function to recover or improvement, helps the dissolving and the drainage of calculus.
The present invention is the medicine of being made by following materials of weight proportions medicine: Herba Lysimachiae 20-80, Herba Dianthi 20-80, Folium Pyrrosiae 10-70, Radix Achyranthis Bidentatae 5-40, Endothelium Corneum Gigeriae Galli 10-60, Cortex Phellodendri 10-60, Radix Paeoniae Rubra 5-30, Pheretima 5-35, Herba Cistanches 5-45, Radix Rehmanniae 10-40, Spora Lygodii 10-50, Cortex Moutan 10-28, Radix Pseudostellariae 10-30, rhizoma sparganic 5-18, Rhizoma Curcumae 10-18, Rhizoma Corydalis 10-40, Herba Polygoni Avicularis 10-40, Radix Et Rhizoma Rhei 4-20, Flos Lonicerae 10-40, Semen Arecae 10-30.
Crude drug optimum ratio scope of the present invention is: Herba Lysimachiae 30-50, Herba Dianthi 30-50, Folium Pyrrosiae 20-50, Radix Achyranthis Bidentatae 10-20, Endothelium Corneum Gigeriae Galli 20-40, Cortex Phellodendri 20-40, Radix Paeoniae Rubra 10-15, Pheretima 10-20, Herba Cistanches 10-20, Radix Rehmanniae 15-30, Spora Lygodii 20-30, Cortex Moutan 15-25, Radix Pseudostellariae 15-28, rhizoma sparganic 10-15, Rhizoma Curcumae 12-18, Rhizoma Corydalis 20-30, Herba Polygoni Avicularis 20-30, Radix Et Rhizoma Rhei 8-18, Flos Lonicerae 20-30, Semen Arecae 15-20.
Preparation method: with above-mentioned except that Spora Lygodii remaining medicinal decocting boil three times, each 30-40 minute, concentrate medicinal liquid, this medicinal liquid cooperates with Spora Lygodii to be taken.
Medicine of the present invention belongs to pure Chinese medicinal preparation, and treatment many cases (100 many cases) patient all has no side effect, and the calculus dissolving and excreting curative effect is fast, generally takes 24 hours produce effects.The calculus jam causes moderate pain, the person of expanding, and does not need the anti-inflammatory and antalgic treatment, only takes this medicine and gets final product., obey every day three times several patient treatments with medicine of the present invention, obey 30-35ml (milliliter) at every turn, add Spora Lygodii 2-7 gram, cured in 2-20 days, show that with B ultrasonic it is criterion of cure that calculus disappears, effective percentage reaches more than 90%, and healing back relapse rate is very low.
Medicine of the present invention has the improvement effect to renal function, and renal calculus, urinary stone, ureteral calculus, vesical calculus etc. are all had good therapeutic effect; For the repeated relapsing urinary system infection curative effect is preferably arranged also.
Medicine of the present invention can be described as the also not high Chinese common people of per capita income and has brought Gospel, for the calculus patient provides through crowded, easy treatment means, the ideamonger that also meets " 21 century carries out not having digging and hinders therapy " of World Health Organization's proposition fully, the main trend of having represented future medicine to develop.
Below enumerate the model case explanation:
Example 1, patient, man, 30 years old.When diagnosing, waist is suffered from abdominal pain unbearably, do and find right renal calculus behind the B ultrasonic, diameter 1.7m, through take this medicine after 8 days pain disappear, after do B ultrasonic left side kidney, ureter, bladder and do not find calculus.
Example 2, patient, man, 38 years old.When diagnosing.Waist abdomen pain, through ultrasound diagnosis, two renal calculuss are many pieces of shapes, and big person 0.3cm * 1.2cm took this medicine after 4 days, and pain disappears, and confirms through B ultrasonic, and calculus disappears.
Example 3, patient, man, 54 years old.Find earlier sufficient root pain, invalid through multi-treatment, after confirm two renal calculuss through B ultrasonic, left kidney 0.3cm, right kidney 0.7cm because of original tuberculous meningitis, so dosage littler (each 20ml), took this medicine 12 days after the disappearance of ultrasound diagnosis calculus.
Example 4, patient, man, 35 years old.When diagnosing, the waist angina abdominis, asthenic body, pale complexion is through ultrasound diagnosis, right renal calculus diameter 1.9cm, ureteral calculus 1.2cm. vesical calculus 0.8cm takes the pain relief after 2 days of this medicine, obeys one and half Mi Dashi grains of urethra discharge after 7 days again, cure behind the clothes to 8 day, through B ultrasonic pick up have a medical check-up in no calculus.
Example 5, the patient, the woman, 28 years old, waist stomachache 1 month was surplus when examining, and finds right renal calculus 0.5cm through ultrasound diagnosis, takes this medicine after 2 days, disappears through B ultrasonic inspection calculus.
The specific embodiment
Embodiment 1:
Get crude drug (unit of weight: restrain): Herba Lysimachiae 20, Herba Dianthi 20, Folium Pyrrosiae 10, Radix Achyranthis Bidentatae 5, Endothelium Corneum Gigeriae Galli 10, Cortex Phellodendri 10, Radix Paeoniae Rubra 5, Pheretima 5, Herba Cistanches 5, Radix Rehmanniae 10, Spora Lygodii 10, Cortex Moutan 10, Radix Pseudostellariae 10, rhizoma sparganic 5, Rhizoma Curcumae 10, Rhizoma Corydalis 10,
Figure S07165712120070403D000041
Hold 10, Radix Et Rhizoma Rhei 4, Flos Lonicerae 10, Semen Arecae 10.
Preparation method: with above-mentioned except that Spora Lygodii remaining medicinal decocting boil three times, each 30-40 minute, afterwards medicinal liquid is concentrated into 200ml, the medicinal liquid of making cooperates with Spora Lygodii to be taken.
Embodiment 2:
Get crude drug (unit of weight: restrain): Herba Lysimachiae 35, Herba Dianthi 35, Folium Pyrrosiae 20, Radix Achyranthis Bidentatae 10, Endothelium Corneum Gigeriae Galli 20, Cortex Phellodendri 20, Radix Paeoniae Rubra 10, Pheretima 10, Herba Cistanches 10, Radix Rehmanniae 10, Spora Lygodii 20, Cortex Moutan 20, Radix Pseudostellariae 20, rhizoma sparganic 10, Rhizoma Curcumae 12, Rhizoma Corydalis 20,
Figure S07165712120070403D000042
Hold 20, Radix Et Rhizoma Rhei 8, Flos Lonicerae 23, Semen Arecae 15.
Preparation method is identical with embodiment 1.
Embodiment 3:
Get crude drug (unit of weight: restrain): Herba Lysimachiae 45, Herba Dianthi 45, Folium Pyrrosiae 30, Radix Achyranthis Bidentatae 16, Endothelium Corneum Gigeriae Galli 30, Cortex Phellodendri 28, Radix Paeoniae Rubra 13, Pheretima 12, Herba Cistanches 15, Radix Rehmanniae 25, Spora Lygodii 30, Cortex Moutan 25, Radix Pseudostellariae 28, rhizoma sparganic 12, Rhizoma Curcumae 16, Rhizoma Corydalis 25,
Figure S07165712120070403D000043
Hold 26, Radix Et Rhizoma Rhei 8, Flos Lonicerae 23, Semen Arecae 17.
Preparation method is identical with embodiment 1.
Embodiment 4:
Get crude drug (unit of weight: restrain): Herba Lysimachiae 80, Herba Dianthi 80, Folium Pyrrosiae 70, Radix Achyranthis Bidentatae 40, Endothelium Corneum Gigeriae Galli 60, Cortex Phellodendri 60, Radix Paeoniae Rubra 30, Pheretima 35, Herba Cistanches 45, Radix Rehmanniae 40, Spora Lygodii 50, Cortex Moutan 28, Radix Pseudostellariae 30, rhizoma sparganic 18, Rhizoma Curcumae 18, Rhizoma Corydalis 40,
Figure S07165712120070403D000044
Hold 40, Radix Et Rhizoma Rhei 20, Flos Lonicerae 40, Semen Arecae 30.
Preparation method is identical with embodiment 1.

Claims (2)

1. medicine for the treatment of renal calculus is characterized in that it is the medicine of being made by following materials of weight proportions medicine:
Herba Lysimachiae 20-80, Herba Dianthi 20-80, Folium Pyrrosiae 10-70, Radix Achyranthis Bidentatae 5-40, Endothelium Corneum Gigeriae Galli 10-60, Cortex Phellodendri 10-60, Radix Paeoniae Rubra 5-30, Pheretima 5-35, Herba Cistanches 5-45, Radix Rehmanniae 10-40, Spora Lygodii 10-50, Cortex Moutan 10-28, Radix Pseudostellariae 10-30, rhizoma sparganic 5-18, Rhizoma Curcumae 10-18, Rhizoma Corydalis 10-40 , Herba Polygoni Avicularis 10-40, Radix Et Rhizoma Rhei 4-20, Flos Lonicerae 10-40, Semen Arecae 10-30;
With above-mentioned except that Spora Lygodii remaining medicinal decocting boil three times, each 30-40 minute, concentrate medicinal liquid, this medicinal liquid cooperates with Spora Lygodii to be taken.
2. the medicine of treatment renal calculus according to claim 1 is characterized in that it is the medicine of being made by following materials of weight proportions medicine:
Herba Lysimachiae 30-50, Herba Dianthi 30-50, Folium Pyrrosiae 20-50, Radix Achyranthis Bidentatae 10-20, Endothelium Corneum Gigeriae Galli 20-40, Cortex Phellodendri 20-40, Radix Paeoniae Rubra 10-15, Pheretima 10-20, Herba Cistanches 10-20, Radix Rehmanniae 15-30, Spora Lygodii 20-30, Cortex Moutan 15-25, Radix Pseudostellariae 15-28, rhizoma sparganic 10-15, Rhizoma Curcumae 12-18, Rhizoma Corydalis 20-30 , Herba Polygoni Avicularis 20-30, Radix Et Rhizoma Rhei 8-18, Flos Lonicerae 20-30, Semen Arecae 15-20.
CN2007100657121A 2007-03-14 2007-03-14 Medicine for treating renal calculus Expired - Fee Related CN101020033B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007100657121A CN101020033B (en) 2007-03-14 2007-03-14 Medicine for treating renal calculus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007100657121A CN101020033B (en) 2007-03-14 2007-03-14 Medicine for treating renal calculus

Publications (2)

Publication Number Publication Date
CN101020033A CN101020033A (en) 2007-08-22
CN101020033B true CN101020033B (en) 2010-07-28

Family

ID=38707960

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007100657121A Expired - Fee Related CN101020033B (en) 2007-03-14 2007-03-14 Medicine for treating renal calculus

Country Status (1)

Country Link
CN (1) CN101020033B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104001082A (en) * 2014-06-13 2014-08-27 刘玉栋 Traditional Chinese medicine for treating damp-heat stasis type kidney calculi

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101455829B (en) * 2008-12-30 2013-03-20 杨爱群 Traditional Chinese medicine capsules for dissolving removing urinary calculus in urinary system
CN101637548B (en) * 2009-03-23 2011-06-15 路正平 Medicine for treating kidney stone and preparation method thereof
CN102028893A (en) * 2010-11-23 2011-04-27 谢连新 Traditional Chinese medicine composition used for treating vesical calculus
CN103877457B (en) * 2014-04-10 2014-11-05 马忠堂 Chinese medicinal preparation for treating renal calculus and preparation method thereof
CN104474044A (en) * 2014-12-05 2015-04-01 福建中合医药股份有限公司 Traditional Chinese medicine composition for treating urinary calculus as well as preparation method and application thereof
CN113209236A (en) * 2021-06-01 2021-08-06 台州市中西医结合医院 Traditional Chinese medicine for treating calculus and application

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1218684A (en) * 1998-10-30 1999-06-09 阎作礼 Capsule for expelling stone
CN1453003A (en) * 2002-04-27 2003-11-05 付增华 Calculus dissolving and excreting capsule
CN1615990A (en) * 2004-09-11 2005-05-18 丁章森 Capsule for treating cholelithiasis
CN1720945A (en) * 2005-06-28 2006-01-18 郑阿权 Medicine for treating calculus in urinary system

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1218684A (en) * 1998-10-30 1999-06-09 阎作礼 Capsule for expelling stone
CN1453003A (en) * 2002-04-27 2003-11-05 付增华 Calculus dissolving and excreting capsule
CN1615990A (en) * 2004-09-11 2005-05-18 丁章森 Capsule for treating cholelithiasis
CN1720945A (en) * 2005-06-28 2006-01-18 郑阿权 Medicine for treating calculus in urinary system

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
刘月荫等.中药治疗输尿管结石41例.河北中医13 3.1991,13(3),14.
刘月荫等.中药治疗输尿管结石41例.河北中医13 3.1991,13(3),14. *
李世美."内金排石汤"治疗泌尿系统结石60例.江苏中医药26 11.2005,26(11),81.
李世美."内金排石汤"治疗泌尿系统结石60例.江苏中医药26 11.2005,26(11),81. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104001082A (en) * 2014-06-13 2014-08-27 刘玉栋 Traditional Chinese medicine for treating damp-heat stasis type kidney calculi

Also Published As

Publication number Publication date
CN101020033A (en) 2007-08-22

Similar Documents

Publication Publication Date Title
CN101020033B (en) Medicine for treating renal calculus
CN101732660A (en) Chinese medicinal preparation for treating prostate disease and preparation method thereof
CN102228603B (en) Chinese medicine for treating retention of urine
CN101406535B (en) Chinese medicinal decoction for treating urinary lithiasis
CN103520680A (en) Traditional Chinese medicine for treating acute heart failure
CN101195011B (en) Chinese medicine for treating prostatitis and hyperplasia
CN101658644B (en) Internal administration medicament for treating urolithiasis disease
CN103585585B (en) A kind of Chinese medicine composition for the treatment of choledocholithiasis and preparation method thereof
CN103285183B (en) Traditional Chinese medicine for treatment of uremia
CN102872362B (en) Traditional Chinese medicine for treating chronic cholecystitis
CN1634385A (en) Chinese traditional medicine composition for treating hydrocephalus, cerebral edema and intracranial hypertension
CN102579981A (en) Traditional Chinese medicine for treatment of gallstone
CN102145150B (en) Medicine for treatment of uninary calculi
CN1166972A (en) Green powder medicine for discharging calculus stone
CN102038879A (en) Longhairy antenoron herb calculus-removing pill
CN101732624A (en) Formula for treating ureteral calculi and preparation method thereof
CN100444877C (en) A Chinese medicine for treating cholecystitis
CN105998880A (en) Oral medicine for treating hemorrhoids, and preparation method thereof
CN101590194A (en) Traditional Chinese medicine for treating urinary calculus
CN100371006C (en) Chinese traditional medicine formula for curing cysticercosis
CN105343290A (en) Traditional Chinese medicine composition for treating kidney qi deficiency type urolithic stranguria
CN103768533A (en) Chinese medicine for treating urinary system lithiasis
CN104873861A (en) Traditional Chinese medicine for treating prostatic hyperplasia
CN1589887A (en) Medicial composition for treating lithiasis and its preparation method
CN101721656B (en) Medicine composition for curing lithiasis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100728

Termination date: 20140314